ImmunoPET for prostate cancer in the PSMA era: do we need other targets?

ConclusionImmunoPET pre-clinical studies have identified several biomarkers with potentially high impact on PC theranostics.
Source: Clinical and Translational Imaging - Category: Radiology Source Type: research